%20HPLC%20vs%20LC-MS.png)
While analyzing research peptides, a Certificate of Analysis
(CoA) can give much more relevant information than a purity percentage quoted
in a headline. The problem here is how to interpret those analytical data.
Researchers usually see HPLC
and LC-MS data, and want to know whether one test is enough, what can be proven
by each of them, and how to analyze a CoA.
A proper CoA links a certain product to a certain batch, and
also describes the analytical methods that were applied to analyze this
product. Knowing all of this will enable researchers to make an informed
decision regarding peptide identity, purity, consistency and reproducibility.
This guide will explain how to analyze a peptide CoA, how HPLC and LC-MS data
can speak about research peptides,
their limitations, and what to look for while choosing a research peptide
supplier.
Understanding a Peptide Certificate of Analysis
Certificate of Analysis is a quality control document that
refers to a specific material or batch. It usually includes, depending on the
vendor and testing lab, data such as product name, batch number, date of
analysis, method of analysis, results for identity, purity, molecule, and other
quality parameters.
In the context of peptide studies, the separation between
these two quality criteria is especially significant. Identity answers the
question “Is this the right peptide?” While purity answers the question “How
much of this analyzed material relates to the measured principal component?”
These are related concepts, however, they cannot be used
interchangeably.
Thus, HPLC purity in the CoA report cannot be viewed as an
all-embracing proof of molecular identity. Similarly, a mass spectrometry
identity result is not an all-encompassing description of all possible
contaminants.
Why CoA Documentation Matters in Peptide Research
Work using peptides requires knowledge about the material
used in the experiment. The material can differ in identity, purity, and
degradation, among other things, which could make the interpretation and
reproducibility difficult.
Therefore, for researchers, batch-based documentation can
help in the following areas:
• Linking the
experiment with the use of material;
• Documenting
the analysis of the material in terms of its identity and purity;
• Comparing
different batches;
• Solving
unusual experiment outcomes;
• Laboratory
documentation; and
• Reproducibility
when reordering materials.
The characterization of peptides is a complex process due to
the influence of different elements on the separation and detection of
peptides. Literature reviews have mentioned chromatography and mass
spectrometry as two key methods for the characterization of synthetic peptides
and their impurities.
HPLC: What It Tells You About Purity
HPLC is a technique for separating chemical components
during their passage through the chromatographic system. In case of peptides,
the method of choice is reversed phase HPLC, which is widely employed for
separation of a target peptide from a mixture of similar substances and others.
Usually, the resulting plot consists of detector responses
in relation to retention times, and scientists can analyze peaks. Depending on
the validated method and reporting practice, one can determine the purity level
in terms of chromatography.
One more important issue is that “99% HPLC purity” means not
that the compound was proved to contain precisely 99% of the desired peptide.
This purity level depends on a number of factors such as method, detector
response, chromatographic conditions, integration, co-elution and measured
substances. That is why a good CoA should contain information about the method.
LC-MS: What It Adds
LC-MS, liquid chromatography-mass spectrometry, is
the combination of separation through liquid chromatography and analysis by
mass spectrometry.
Here, the process of liquid chromatography will involve
separating the mixture of molecules, while the mass spectrometer will analyze
the ionized molecules on the basis of their mass-to-charge ratio. It can
provide support for the identity of the molecule being analyzed and also
characterize some of the impurities present in the molecules.
The significance of the method lies in the fact that both
these techniques have complementary information. According to the research
literature, LC-MS is a very potent technique for analyzing peptides. It doesn’t
imply that LC-MS has made HPLC redundant.
How HPLC and LC-MS Work Together
The simplified procedure involves:
1. Sample
preparation – Preparation of an appropriate sample for analysis.
2. Separation –
The sample is separated by passing through the HPLC or LC.
3. Detection –
HPLC uses an appropriate detector to form a chromatogram, and LC-MS moves the
separated compounds to a mass spectrometer.
4. Data
interpretation – The analyst interprets the results based on retention time,
peak profile, mass/charge ratio, among others.
5. Reporting –
The results are reported in an analytical report or CoA, if any.
The important thing to note here is that no single value is
looked at independently. A researcher must analyze the method, the result, the
sample or batch number, and what the test can prove.
What Researchers Should Look For
To read a peptide CoA:
• Product
identity: Is the identity of the product consistent with the name or
identifier?
• Batch
number: Is there a specific batch number that corresponds to the
CoA?
• Date of
analysis: Is there a clear date for when the analysis took place?
• Analytical
technique: Does it state the use of HPLC, LC-MS, MS-UPLC, or some other
technique?
• Purity
value: Is the purity value provided?
• Identity
value: Is the identity of the molecule independent of the CoA?
• Laboratory
information: Is the laboratory where analysis took place listed, when
applicable?
• Other
values: Is there any additional information on analytical tests performed?
How much documentation is needed depends on how intensive
the analytical task at hand will be.
Common Misunderstandings
"A high HPLC percentage equals identity."
Not always true, as HPLC gives mostly the separation and
purity data. Identity might require other kinds of data, such as mass
spectrometry.
"LC-MS and HPLC are competing techniques."
In fact, they are complementary techniques. LC-MS means
liquid chromatography combined with mass detection.
"A CoA means all impurities have been
excluded."
It simply says what tests have been done and what the
results were. Lack of one measurement does not imply lack of any other
impurity.
"99% result is always the same in every lab."
Analytical results are dependent on the analytical method
used. Different methods will give results which cannot be compared to each
other.
How to Evaluate Quality and Documentation
A well-designed CoA will enable the researcher to relate the
findings to the specific material.
The bare minimum required is a clearly documented batch and
analytical data. Additional information might depend on the material and its
vendor and might include:
• COA
identification;
• batch/lot
number;
• product name
and, in some cases, the chemical identification;
• date of
testing;
• HPLC purity;
• mass
spectroscopy identity information;
• molecular
weight/formula;
• analytical
methods used;
• laboratory
information/testing facility; and
• any
additional tests performed for quality purposes.
Examples from the scientific literature regarding peptide
reference materials demonstrate how multiple techniques can be employed to
achieve the goal. According to the USP publication, there were multiple
approaches using mass spectroscopy, chromatography, NMR and other analytical
techniques when developing identity, purity, content and consistency of the
peptides.
In conclusion, it should be stressed that it is important to
read the whole COA, not just the purity percentage.
PeptidesX Approach to Research-Grade Transparency
"PeptidesX provides only peptides for laboratory and
scientific research and not for human, veterinary, medical or therapeutic
use," the company's own published materials say about the company's
products. Published materials from the company detail batch-specific CoAs and
independent testing by means of HPLC and mass spectrometry.
It also publishes information about its testing process,
including claims that batches are subject to independent HPLC testing and mass
spectrometry for identity. Researcher needs to check these claims based on
batch documentation provided by the company instead of simply believing
marketing messages.
This is important whatever supplier is used because the
documentation must provide enough information to determine what was tested,
what batch was tested, how it was tested, and what was demonstrated by the test
results.
What to Consider Before Choosing a Research Peptide
Supplier
The following checklist of factors to look at while
evaluating peptide suppliers is a useful tool:
1. Documentation
– Is the CoA easily accessible and clear?
2. Batch
documentation – Does the CoA pertain to the batch in question, not just the
general product?
3. Analytical
techniques – Are HPLC or mass spectrometry methods mentioned?
4. Product
description – Are the names, amounts, IDs, and research restrictions of the
products specified?
5. Distinction
between research products and commercial/ veterinary – Does the supplier make
the difference between the two clear?
6. Business
transparency – Is there an identifiable company and contact information?
7. Customer
care – Do researchers have an opportunity to clarify analytical documentation?
8. Traceability
– Is there enough data available to trace back to the quality documents the
purchased product?
While looking for UK peptide suppliers, these factors become
far more important than the comparison of advertised purity percentages of
different products.
Frequently Asked Questions
What is the difference between HPLC purity and LC-MS
identity?
HPLC is a common technique for separation of constituents
and assessment of purity, while LC-MS employs liquid chromatography and mass
spectrometry for determination of molecular weight and identity. As the two
techniques address different types of analytical questions, they are usually
more helpful together, than one considered a substitute for another.
Is 99% HPLC purity enough to confirm a peptide's
identity?
No. High chromatographic purity does not indicate that
molecular identity is known. The confirmation of identity requires mass
spectrometry or any other analytical technique. Scientists should check whether
the CoA contains both the purity value and the identity test.
What should a peptide CoA contain?
Not really, there is no universal format for all research
materials. However, useful documentation would contain product and batch
identification, testing date, testing method, HPLC purity, mass-spectrometric
identity data, molecular data, and testing laboratory identification.
Can different HPLC purity results be compared directly?
Not necessarily. HPLC analysis will depend on certain
parameters of the process itself, such as the particular chromatographic
technique used and type of detection involved. When comparing HPLC results from
different sources, scientists need to make sure the techniques are comparable
enough.
Does LC-MS replace HPLC?
Incorrect. LC-MS includes not just liquid chromatography but
also mass spectrometry, which provides additional information that cannot be
gained using regular HPLC detection. Nonetheless, the chromatography itself is
still relevant in the context of analysis and related substances.
Does a CoA guarantee that a research peptide is suitable
for every experiment?
Incorrect. Certificate of Analysis proves certain parameters
of the product; however, it is not enough for all sorts of experiments.
Scientists should think about what parameters they might need depending on the
study, such as identity, purity, storage conditions, stability, composition,
and other tests.
Are research peptides approved for human or veterinary
use?
Materials for research purposes must not be treated as being
fit for human or veterinary use. The manufacturer explicitly claims that the
products of PeptidesX are intended exclusively for research use only.
Regulatory agencies distinguish research products from clinically
approved/cleared products.
Conclusion
Rather than looking for the highest purity figure in reading
a peptide CoA, the underlying process involves understanding the reasoning
behind the data. HPLC provides important data regarding the purity of a
peptide, whereas LC-MS adds evidence in terms of the identity and mass of the
molecule. The batch numbers, testing dates, analytical techniques, and lab
details allow one to link these data points to specific research material.
From the perspective of a scientist assessing peptides, it
means that one should analyze the available documentation and understand its
limits. Although PeptidesX provides
batch-specific documentation and research material, the above process applies
to any manufacturer.
Sources & References
- Sharma N, Kukreja D, Giri T, Kumar S, Shah RP. “Synthetic pharmaceutical peptides characterization by chromatography principles and method development.” Journal of Separation Science (2022).
- Muttenthaler-related peptide characterization literature and broader analytical approaches are discussed in the peer-reviewed review “New and Evolving Techniques for the Characterization of Peptide Therapeutics.”
- “Characterization of Synthetic Peptide Therapeutics Using Liquid Chromatography-Mass Spectrometry: Challenges, Solutions, Pitfalls, and Future Perspectives.” Journal of Pharmaceutical Sciences / PubMed-indexed review.
- “Reference Standards to Support Quality of Synthetic Peptide Therapeutics.” Pharmaceutical Research (2023), describing analytical approaches including mass spectrometry, chromatography, NMR, content assignment, and stability studies.
- FDA, Research Use Only / Investigational Use Only guidance and information, for the distinction between research-use materials and clinical diagnostic applications.
- PeptidesX, Research Use Only, FAQ, and About Us pages, used only for claims specifically describing PeptidesX's published policies and documentation.